CORAL GABLES, FL / ACCESSWIRE / February 5, 2019 / The marijuana stock market has seen copious amounts of changes over the course of the past few years, but 2019 has given the industry reason to ramp up production, following the introduction of several pieces of positive legislation in favor of legalizing marijuana. Including the 2018 year, marijuana continues to look as though it could be legalized on a federal level sometime in the near future. One of the key favors of this is that the vast majority of the public is actively in favor of cannabis legalization. As a result of the increase in favorable opinion, investors looking for potential opportunities have shifted their focus to the cannabis industry. With February underway, Future Farms Technologies Inc (CSE: FFT) (OTCQB: FFRMF), Aurora Cannabis Inc (NYSE: ACB), Canopy Growth Corp (NYSE: CGC) (TSX: WEED), and Aphria Inc (NYSE: APHA) are 4 pot stocks picking up speed on Tuesday.
Future Farms Technologies Inc (CSE: FFT) (OTCQB: FFRMF) is a publicly traded Canadian company that acquires and develops a diversified portfolio of projects in the cannabis and agricultural technology sectors. The Company is comprised of innovative decision makers, at the top of their field, devoted to assuring compliance behind every move they make on behalf of their partners, investors, and consumers.
Future Farms Technologies Inc (CSE: FFT) (OTCQB: FFRMF) is focused on four key market segments in the cannabis industry, namely cultivation, processing and breeding genetics, retail, and technologies meant to advance the sector as a whole.
In recent news, Future Farms Technologies Inc (CSE: FFT) (OTCQB: FFRMF) today announced that it has reached an agreement with its Puerto Rico partner, TCG Investments, LLC, owner of the ''Clínica Verde'' brand of medical cannabis dispensaries, to expand its ownership interest in its Puerto Rico subsidiary, FFPR, LLC (''FFPR''). Per the details of the announcement, Future Farm and TCG intend to purchase their former business partner's interest, resulting in Future Farm owning a 50% ownership interest and 60% economic interest. Future Farm previously held a 40% ownership interest and 50% economic interest in FFPR.
Following the announcement of the agreement, William Gildea, CEO of Future Farms Technologies Inc (CSE: FFT) (OTCQB: FFRMF), commented, ''Puerto Rico is a strategic location for Future Farm expansion given its soaring patient population and increasing social acceptance of medical cannabis. We are excited to continue building out the Clinica Verde dispensaries to provide legal, quality flower, edibles and concentrates to patients residing on and visiting Puerto Rico at this time of island-wide restoration and growth.''
For More Information On Future Farms Technologies Inc, Click Here
Aurora Cannabis Inc (NYSE: ACB) announced earlier this week that its extraction technology partner, Radient Technologies, has received its Standard Processing License from Health Canada. Since investing in Radient, Aurora has gained entrance into the hemp sector with its majority ownership of Hemp Food and Fiver and the acquisition of AgroPro, Europe's largest producer of organic hemp products.
Terry Booth, CEO of Aurora Cannabis, said, ''with the upcoming new regulations permitting additional form factors and Radient's recent receipt of its processor license, we are in a strong position to rapidly expand production of a broad portfolio of extract-based products, tying in well with the significant scale-up of our global cannabis and hemp operations.''
For More Information On Aurora Cannabis Inc, Click Here
Canopy Growth Corp (NYSE: CGC) (WEED) announced towards the end of January that the Company had made key European progress in the UK and Poland where its medically-focused business Spectrum Cannabis continues to build a sophisticated, pan-European cannabis production and distribution network serving the needs of physicians and their patients throughout the continent.
In terms of the Company's presence in the United Kingdom, Spectrum Biomedical UK was formed as a joint venture between Canada's Canopy Growth and Oxford-based research-company Beckley Canopy Therapeutics to address a groundswell of patient need for high quality, standardized cannabis-based medicinal products in the UK. Under the British government's new classification, which took effect November 1, specialist doctors in the UK can prescribe cannabis-based medicines to patients managing a wide range of symptoms.
For More Information On Canopy Growth Corp, Click Here
Aphria Inc (APHA) announced early last week that the Company had completed its first transfer of plant cuttings from four of the Company's cannabis strains to Denmark- based Schroll Medical, as part of the Company's previously announced Strategic Partnership with Schroll. The shipment was completed under permits issued by the relevant health authorities, including an export permit from Health Canada, an import permit from the Danish Medicines Agency and a phytosanitary certificate from the Canadian Food Inspection Agency.
Per the details of the announcement, Aphria will handle the worldwide distribution of medical cannabis produced by the Partnership, which is anticipated to be made available to markets across Europe as medical cannabis markets develop. Aphria plans to complete the second shipment of additional strains to Schroll in the coming months.
For More Information On Aphria Inc, Click Here
About marijuanastocks.com
MarijuanaStocks.com is the leading web destination for all things cannabis. Investors can find marijuana-related financial, medical, legal, and social news anytime day or night. Writers are invited to submit cannabis related articles for publication.
Legal Disclaimer
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. MAPH Enterprises LLC which owns www.MarijuanaStocks.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. MAPH Enterprises LLC, which owns www.MarijuanaStocks.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. MAPH Enterprises LLC, which owns www.MarijuanaStocks.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. We have not been compensated by any of the companies mentioned within this release. For disclaimer information, click here.
Contact Information:
SOURCE: MarijuanaStocks.com